Trial Profile
A Multicenter Controlled Open-label Trial of Evaluating Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate and Entecavir in Acute-on-chronic Liver Failure of Chronic Hepatitis B Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Feb 2023
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir alafenamide (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 07 Feb 2023 Planned End Date changed from 1 Jul 2022 to 1 Jul 2023.
- 02 May 2019 Planned End Date changed from 1 Mar 2025 to 1 Jul 2022.
- 02 May 2019 Planned primary completion date changed from 1 Mar 2024 to 1 Apr 2021.